Some biological activities displayed by cord factor (CF), a glycolipid extractable from mycobacteria (11) , are similar to those of living BCG. Both, after intravenous (i.v.) injection into mice, induce lung granulomas composed of epithelioid cells, macrophages, and lymphocytes (2). Administration of cord factor (CF) or BCG into the footpads of mice causes formation of granulomas, marked hyperplasia of the lymphoid tissue in the paracortical zone, and accumulation of macrophages in the draining lymph nodes (3). Mice injected with both agents into the footpads react with increased antibody response to an unrelated antigen subsequently injected into the same site (7, 15) . This increased antibody formation has been related to the granulomatous reaction induced in the draining lymph nodes (7) . Mice with lung granulomas induced by CF were protected against i.v. challenge with the virulent H37Rv strain of Mycobacterium tuberculosis, a protection similar to that observed by others after i.v. injection of intact mycobacterial cells (2, 22, 23) . It was observed that CF activates peritoneal macrophages of mice in vivo as judged by an increased acid phosphatase activity and increased phagocytic activity of Listeria monocytogenes. This activation was comparable to that induced by heat-killed or living BCG (E. Yarkoni and A. Bekierkunst, in preparation). Living BCG bacilli are able to stimulate the immunological response of the host, as evident in nonspecific resistance to heterologous bacterial injections as well as to grafted tumors in animals sensitized with BCG (4, 5, 8, 10, 13, 14, 17) . This immunopotentiating activity is also evident in suppression and regression of intradermal tumors and prevention of their metastases in guinea pigs by injection of living BCG or oil emulsions of nonliving BCG cells or cell walls into the tumors (6, 9, (24) (25) (26) . An important role in tumor regressive activity was related to CF (1, 6), which is apparently identical to P3 (11, 15) .
We now report the induction of nonspecific resistance against infection with Salmonella bacilli by CF and its synthetic analogues.
MATERIALS AND METHODS Animals. Locally bred albino mice were used throughout.
Bacteria. Salmonella typhi strain Ty2, obtained from our stock, and Salmonella typhimurium strain SR 11, obtained from L. J. Berry (Department of Microbiology, University of Texas, Austin), were grown at 370C in tryptic soy agar (Difco) for 16 to 18 h. The mean lethal dose ofS. typhi strain Ty2 was 6 x 106 bacteria, and that ofS. typhimurium strain SR 11 was less than 10 bacteria.
Preparation of emulsions and other materials. CF, its synthetic analogues, and their emulsions were prepared as described previously (2, 18, 19, 21 resistance. Earlier observation showed that not only CF but also its analogues increased the host resistance to Ehrlich ascites tumor cells (20) . A study of the nonspecific resistance against Salmonella infections induced with analogues was therefore indicated. The analogues trehalose monopalmitate and trehalose-6,6'-dipalmitate were tested. Groups of 10 mice were pretreated i.p. with the analogues in oil-inwater emulsions and challenged 3 days later. Both were highly effective in induction of nonspecific resistance against S. typhi (up to 100% of mice survived) ( Table 6 , experiments 1 and 2); however, only trehalose-6,6'-dipalmitate brought about resistance against S. typhimurium (60% survivors), whereas trehalose monopalmitate was not effective (experiments 3 and 4). DISCUSSION It is clear that in mice, pretreatment with CF induces nonspecific resistance against S. typhi Ty2 and S. typhimurium. Another fact shown by this study is the local effect of CF. The latter injected i.v. has no inhibitory effect on the VOL. 14, 1976 on October 11, 2017 by guest http://iai.asm.org/ Downloaded from (12) . Such activated macrophages probably play an important role in increased resistance to virulent bacteria. CF has been shown to be effective in prevention (4, 21) and in immunotherapy oftumors in guinea pigs (1, 6) and humans (H. Cohen and A. Bekierkunst, in preparation), and in combination with nonliving BCG it was used for preparing a tumor vaccine (1). These activities of CF indicate that it may be useful as an adjunct in preparing effective vaccines against bacteria.
The results of the experiments in the present study with the CF analogues trehalose monopalmitate and trehalose-6,6'-dipalmitate indicate that the mycolic acid moiety is not essential for the activity observed; mycolic acid can be replaced by palmitic acid. Similar results were observed with these analogues in granulomagenic and tumor-suppressive activity in mice (20) . It has recently been shown that trehalose-6,6'-dipalmitate and trehalose-6,6'-dibehenate can partially substitute for CF in its tumor-regressive activity in guinea pigs (A. Bekierkunst and E. Lederer, in preparation) . Synthetic analogues of CF such as trehalose-6,6'-dipalmitate and trehalose-6,6'-dibehenate, as well as monoesters, open the way for possible use of these substances as adjuncts in preparation of specific active vaccines against tumors and other infectious agents. ACKNOWLEDGMENT We wish to thank E. Lederer (Institut de Chimie des Substances Naturelles, Gif-sur-Yvette, France) for the generous supply of cord factor and its analogues. LITERATURE CITED 1. Bekierkunst, A. 1975 . Immunotherapy and vaccination against cancer with nonliving BCG and cord factor (trehalose-6,6'-dimycolate). Int. J. Cancer 16:442- 447.
